Human Menstrual Blood-Derived Mesenchymal Cells Improve Mouse Embryonic Development

There is a constant need for improving embryo culture conditions in assisted reproduction. One possibility is to use mesenchymal stem/stromal cells derived from menstrual blood (mbMSCs), with an endometrial origin. In this study, we sought to analyze the expansion of mouse embryos in a direct cocult...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tissue engineering. Part A 2020-07, Vol.26 (13-14), p.769-779
Hauptverfasser: Goncalves, Marianna Ferreira, Asensi, Karina Dutra, Lima Nascimento, Anna Luiza, Oliveira de Barros, Julia Helena, Santos, Rosana de Almeida, Vieira de Andrade, Cherley Borba, Kasai-Brunswick, Tais Hanae, Frajblat, Marcel, Ortiga-Carvalho, Tania M., dos Santos Goldenberg, Regina Coeli
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:There is a constant need for improving embryo culture conditions in assisted reproduction. One possibility is to use mesenchymal stem/stromal cells derived from menstrual blood (mbMSCs), with an endometrial origin. In this study, we sought to analyze the expansion of mouse embryos in a direct coculture model with mbMSCs. Our results showed that after five passages, mbMSCs presented a spindle-shaped morphology, with surface markers that were comparable with the normal mesenchymal cell phenotype. mbMSCs could differentiate into adipogenic and osteogenic lineages and secrete angiopoetin-2 and hepatocyte growth factor. The coculture experiments employed 103 two-cell-stage embryos that were randomly divided into two groups: control ( n  = 50), embryos cultured in GV-Blast medium, and cocultured mbMSCs ( n  = 53), embryos cocultured with GV-Blast and mbMSCs. Typically, two to three embryos were placed in a well with 200 μL of culture medium and observed until developmental day 5. After 5 days, the cocultured group had more embryos in the blastocyst stage (69.8%) when compared with the control group (30%) ( p  
ISSN:1937-3341
1937-335X
DOI:10.1089/ten.tea.2020.0034